This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Jul;66(1):10-9.

doi: 10.1038/bjc.1992.209.

Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents

PMID: 1637658
PMCID: PMC1977896
DOI: 10.1038/bjc.1992.209

Free PMC article

Review

Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents

A Gescher. Br J Cancer. 1992 Jul.

Free PMC article

. 1992 Jul;66(1):10-9.

doi: 10.1038/bjc.1992.209.

Author

PMID: 1637658
PMCID: PMC1977896
DOI: 10.1038/bjc.1992.209

No abstract available

PubMed Disclaimer

Similar articles

[Protein kinase C. Key enzyme for immune reactions and cell growth].
Hellwiq B. Hellwiq B. Med Monatsschr Pharm. 1994 Nov;17(11):326-8. Med Monatsschr Pharm. 1994. PMID: 7823874 Review. German. No abstract available.
The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM. Szallasi Z, et al. Cancer Res. 1996 May 1;56(9):2105-11. Cancer Res. 1996. PMID: 8616857
Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Steube KG, Drexler HG. Steube KG, et al. Leuk Lymphoma. 1993 Jan;9(1-2):141-8. doi: 10.3109/10428199309148517. Leuk Lymphoma. 1993. PMID: 8477194 Review.
Chemistry and clinical biology of the bryostatins.
Mutter R, Wills M. Mutter R, et al. Bioorg Med Chem. 2000 Aug;8(8):1841-60. doi: 10.1016/s0968-0896(00)00150-4. Bioorg Med Chem. 2000. PMID: 11003129 Review.
Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL, Bradshaw TD, Gescher A, Pettit GR. Dale IL, et al. Cancer Res. 1989 Jun 15;49(12):3242-5. Cancer Res. 1989. PMID: 2720677

See all similar articles

Cited by

Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.
Deacon EM, Pongracz J, Griffiths G, Lord JM. Deacon EM, et al. Mol Pathol. 1997 Jun;50(3):124-31. doi: 10.1136/mp.50.3.124. Mol Pathol. 1997. PMID: 9292146 Free PMC article. Review. No abstract available.
Review of survival analyses published in cancer journals.
Altman DG, De Stavola BL, Love SB, Stepniewska KA. Altman DG, et al. Br J Cancer. 1995 Aug;72(2):511-8. doi: 10.1038/bjc.1995.364. Br J Cancer. 1995. PMID: 7640241 Free PMC article.
Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis.
Lord JM, Pongracz J. Lord JM, et al. Clin Mol Pathol. 1995 Apr;48(2):M57-64. doi: 10.1136/mp.48.2.m57. Clin Mol Pathol. 1995. PMID: 16695983 Free PMC article. No abstract available.
Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target.
Hall-Jackson CA, Jones T, Eccles NG, Dawson TP, Bond JA, Gescher A, Wynford-Thomas D. Hall-Jackson CA, et al. Br J Cancer. 1998 Sep;78(5):641-51. doi: 10.1038/bjc.1998.554. Br J Cancer. 1998. PMID: 9744505 Free PMC article.
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.
Grossman SA, Alavi JB, Supko JG, Carson KA, Priet R, Dorr FA, Grundy JS, Holmlund JT. Grossman SA, et al. Neuro Oncol. 2005 Jan;7(1):32-40. doi: 10.1215/S1152851703000353. Neuro Oncol. 2005. PMID: 15701280 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Int J Cancer. 1991 Jul 30;48(6):803-6 - PubMed
1. FEBS Lett. 1991 Jun 17;284(1):120-2 - PubMed
1. Biochem Biophys Res Commun. 1991 May 15;176(3):1227-31 - PubMed
1. Cancer Res. 1988 Jan 15;48(2):447-51 - PubMed
1. Cancer Res. 1988 Nov 1;48(21):5984-8 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database